DEXAMETHASONE 2 MG PO TABS |
1/615 |
(0.16%) |
10 mg |
DEXAMETHASONE 4 MG PO TABS |
1/615 |
(0.16%) |
16 mg |
DEXAMETHASONE SOD PHOS 10 MG/ML IJ SUPERORDERABLE OHS |
11/615 |
(1.79%) |
(0.8 mg, 10 mg) |
DEXAMETHASONE SOD PHOS 4 MG/ML IJ SUPERORDERABLE OHS |
2/615 |
(0.33%) |
(4 mg, 10 mg) |
DEXAMETHASONE SODIUM PHOSPHATE 10 MG/ML INJ SOLN |
3/615 |
(0.49%) |
10 mg |
DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJ SOLN |
11/615 |
(1.79%) |
(1 mg, 8 mg) |
HYDROCORTISONE NA SUCCINATE PF 100 MG INJ SOLR |
57/615 |
(9.27%) |
(12.5 mg, 100 mg) |
HYDROCORTISONE SOD SUCC 100 MG IJ SOLR SUPERORDERABLE OHS |
16/615 |
(2.60%) |
(25 mg, 100 mg) |
METHYLPREDNISOLONE IVPB 126—999 MG |
1/615 |
(0.16%) |
500 mg |
METHYLPREDNISOLONE SODIUM SUCC 125 MG INJ SOLR |
187/615 |
(30.41%) |
(1 mg, 250 mg) |
METHYLPREDNISOLONE SODIUM SUCC 40 MG INJ SOLR |
431/615 |
(70.08%) |
(20 mg, 80 mg) |
METHYLPREDNISOLONE TO 500 MG IVPB OHS |
2/615 |
(0.33%) |
(40 mg, 500 mg) |
PREDNISONE 20 MG PO TABS |
76/615 |
(12.36%) |
(10 mg, 80 mg) |
PREDNISONE 50 MG PO TABS |
9/615 |
(1.46%) |
50 mg |
HYDROCORTISONE (SOLU-CORTEF) 100 MG INJECTION CABINET OVERRIDE |
4/615 |
(0.65%) |
(45 mg, 100 mg) |
METHYLPREDNISOLONE SODIUM SUCCINATE (SOLU-MEDROL) 125MG / 2ML INJECTION CABINET OVERRIDE |
1/615 |
(0.16%) |
125 mg |
Note: Each of 615 patients who were counted as recipients of corticosteroid treatment was given one or more than one included steroids during hospitalization |
Excluded steroids—as any given medications were recorded in EHR |
PREDNISONE 10 MG PO TABS |
|
|
|
PREDNISONE 5 MG PO TABS |
|
|
|
BUDESONIDE 3 MG PO CPEP |
|
|
|
PREDNISOLONE 5 MG PO TABS |
|
|
|
HYDROCORTISONE 10 MG PO TABS |
|
|
|
PREDNISONE 1 MG PO TABS |
|
|
|
METHYLPREDNISOLONE 4 MG PO TABS |
|
|
|
FLUTICASONE FUROATE-VILANTEROL 100–25 MCG/INH INHAL AEPB |
|
|
|
FLUTICASONE FUROATE-VILANTEROL 200–25 MCG/INH INHAL AEPB |
|
|
|
BUDESONIDE 0.5 MG/2ML INHAL SUSP |
|
|
|
FLUTICASONE PROPIONATE HFA 44 MCG/ACT INHAL AERO |
|
|
|